Scholars International Conference and Exhibition on

Pharmaceutics and Drug Delivery Research

THEME: "Exploring the Challenges in Pre & Post Formulations and Drug Delivery Systems"

img2 21-22 Mar 2022
img2 MENA Plaza Hotel Albarsha, Dubai, UAE
Alaa F. Nahhas’s

Alaa F. Nahhas’s

King Abdulaziz University, Saudi Arabia

Title: The promising use of nano-molecular imprinted templates for improved SARS-CoV-2 detection, drug delivery and research


Biography

Alaa F. Nahhas’s degrees are in biochemistry from the King Abdulaziz University (B.S., 2006) and in biomedical engineering and biotechnology from University of Massachusetts (Ph.D., 2017). She currently serves as an Assistant Professor of Biochemistry at King Abdulaziz University. 

Abstract

Molecular imprinting (MI) is a technique that creates a template of a molecule for improving complementary binding sites in terms of size and shape to a peptide, protein, bacteria, mammalian cell, or virus on soft materials (such as polymers, hydrogels, or self-assembled materials). MI has been widely investigated for over 90 years in various industries but is now focused on improved tissue engineering, regenerative medicine, drug delivery, sensors, diagnostics, therapeutics and other medical applications. Molecular targets that have been studied so far in MI include those for the major antigenic determinants of microorganisms (like bacteria or viruses) leading to innovations in disease diagnosis via solid-phase extraction separation and biomimetic sensors. As such, although not widely investigated yet, MI demonstrates much promise for improving the detection of and treatment for the current Coronavirus Disease of 2019 (COVID-2019) pandemic as well as future pandemics. In this manner, this review will introduce the numerous applications of MI polymers, particularly using proteins and peptides, and how these MI polymers can be used as improved diagnostic and therapeutic tools for COVID-19